Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Intensive surveillance with bi-annual dynamic contrast-enhanced magnetic resonance imaging downstages breast cancer in BRCA1 mutation carriers.

Guindalini RS, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova GF, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston RJ, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar GS, Newstead GM, Huo D, Olopade OI.

Clin Cancer Res. 2018 Aug 28. pii: clincanres.0200.2018. doi: 10.1158/1078-0432.CCR-18-0200. [Epub ahead of print]

PMID:
30154229
2.

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis.

Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O.

Front Oncol. 2018 May 22;8:156. doi: 10.3389/fonc.2018.00156. eCollection 2018. Review.

3.

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer.

Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Beşe N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW.

Cancer Discov. 2018 Mar;8(3):336-353. doi: 10.1158/2159-8290.CD-17-0535. Epub 2017 Dec 14.

PMID:
29242214
4.

Trends in progression-free survival (PFS) and time to progression (TTP) over time within first-line aromatase inhibitors trials in hormone receptor-positive advanced breast cancer.

Reinert T, Debiasi M, Bines J, Barrios CH.

Breast Cancer Res Treat. 2018 Apr;168(2):457-465. doi: 10.1007/s10549-017-4593-x. Epub 2017 Nov 30.

PMID:
29190006
5.

Aspergillus fumigatus-specific immunoglobulin levels in BALF of CF patients.

Goña-Höpler M, Pfaller B, Argeny J, Kanolzer S, Gruber S, Schmidthaler K, Renner S, Nachbaur E, Fucik P, Glaser AG, Debiasi M, Szépfalusi Z, Crameri R, Rhyner C, Eiwegger T.

ERJ Open Res. 2017 Nov 17;3(4). pii: 00067-2017. doi: 10.1183/23120541.00067-2017. eCollection 2017 Oct.

6.

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.

Moreira RB, Debiasi M, Francini E, Nuzzo PV, Velasco G, Maluf FC, Fay AP, Bellmunt J, Choueiri TK, Schutz FA.

Oncotarget. 2017 Aug 8;8(48):84572-84578. doi: 10.18632/oncotarget.20028. eCollection 2017 Oct 13. Review.

7.

Estimation of Premature Deaths From Lack of Access to Anti-HER2 Therapy for Advanced Breast Cancer in the Brazilian Public Health System.

Debiasi M, Reinert T, Kaliks R, Amorim G, Caleffi M, Sampaio C, Fernandes GDS, Barrios CH.

J Glob Oncol. 2016 Jul 20;3(3):201-207. doi: 10.1200/JGO.2016.005678. eCollection 2017 Jun.

8.

Nerve conduits for treating peripheral nerve injuries: A systematic literature review.

Braga Silva J, Marchese GM, Cauduro CG, Debiasi M.

Hand Surg Rehabil. 2017 Apr;36(2):71-85. doi: 10.1016/j.hansur.2016.10.212. Epub 2017 Jan 25.

PMID:
28325431
9.

P1.51: Impact of Regulatory Delays in Drug Approval: Mortality and Morbidity Due to With Lack of Access to Crizotinib in Brazil: Track: Supportive Care and Others.

Barrios PM, Debiasi M, Lopes G, Barrios CH.

J Thorac Oncol. 2016 Oct;11(10S):S215. doi: 10.1016/j.jtho.2016.08.073. Epub 2016 Sep 22. No abstract available.

10.

P1.08: Updated Analysis of Global Epidemiology of EGFR Mutation in Advanced Non-Small Cell Lung Cancer: Track: Prevention, Early Detection, Epidemiology and Tobacco Control.

Werutsky G, Debiasi M, Sampaio FH, Nunes Filho PR, Mathias C, Zukin M, Zaffaroni F, Lopes G.

J Thorac Oncol. 2016 Oct;11(10S):S184-S185. doi: 10.1016/j.jtho.2016.08.030. Epub 2016 Sep 22. No abstract available.

11.

Progress and remaining challenges for cancer control in Latin America and the Caribbean.

Strasser-Weippl K, Chavarri-Guerra Y, Villarreal-Garza C, Bychkovsky BL, Debiasi M, Liedke PE, Soto-Perez-de-Celis E, Dizon D, Cazap E, de Lima Lopes G Jr, Touya D, Nunes JS, St Louis J, Vail C, Bukowski A, Ramos-Elias P, Unger-Saldaña K, Brandao DF, Ferreyra ME, Luciani S, Nogueira-Rodrigues A, de Carvalho Calabrich AF, Del Carmen MG, Rauh-Hain JA, Schmeler K, Sala R, Goss PE.

Lancet Oncol. 2015 Oct;16(14):1405-38. doi: 10.1016/S1470-2045(15)00218-1. Review.

PMID:
26522157
12.

An electronically tunable duct silencer using dielectric elastomer actuators.

Lu Z, Godaba H, Cui Y, Foo CC, Debiasi M, Zhu J.

J Acoust Soc Am. 2015 Sep;138(3):EL236-41. doi: 10.1121/1.4929629.

PMID:
26428819
13.

Cognitive Consequences of Aging with HIV: Implications for Neuroplasticity and Rehabilitation.

Vance DE, McDougall GJ Jr, Wilson N, Debiasi MO, Cody SL.

Top Geriatr Rehabil. 2014 Jan;30(1):35-45.

14.

Planning cancer control in Latin America and the Caribbean.

Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G.

Lancet Oncol. 2013 Apr;14(5):391-436. doi: 10.1016/S1470-2045(13)70048-2.

PMID:
23628188
15.

Is the study power enough to say "no difference"?

Geib G, Debiasi M, Barcellos NT, Wolff FH.

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e37; author reply e37-8. doi: 10.1097/QAI.0b013e31822b4ef2. No abstract available.

PMID:
21921724
17.

Inhaled corticosteroid treatment and growth of asthmatic children seen at outpatient clinics.

Arend EE, Fischer GB, Debiasi M, Schmid H.

J Pediatr (Rio J). 2006 May-Jun;82(3):197-203.

18.
19.

Impaired vascular contractility and blood pressure homeostasis in the smooth muscle alpha-actin null mouse.

Schildmeyer LA, Braun R, Taffet G, Debiasi M, Burns AE, Bradley A, Schwartz RJ.

FASEB J. 2000 Nov;14(14):2213-20.

PMID:
11053242
20.

Nicotine activates and desensitizes midbrain dopamine neurons.

Pidoplichko VI, DeBiasi M, Williams JT, Dani JA.

Nature. 1997 Nov 27;390(6658):401-4.

PMID:
9389479
21.

An aggregating elastin-like pentapeptide.

Morelli MA, DeBiasi M, DeStradis A, Tamburro AM.

J Biomol Struct Dyn. 1993 Aug;11(1):181-90.

PMID:
8216943
22.

A single nonpolar residue in the deep pore of related K+ channels acts as a K+:Rb+ conductance switch.

Kirsch GE, Drewe JA, Taglialatela M, Joho RH, DeBiasi M, Hartmann HA, Brown AM.

Biophys J. 1992 Apr;62(1):136-43; discussion 143-4.

Supplemental Content

Loading ...
Support Center